Friday, Jan 27 2023 | Time 17:02 Hrs(IST)
Business Economy

Indira IVF partners with Maven Clinic

Mumbai, Nov 30 (UNI) Indira IVF, India’s largest chain of infertility treatments, has announced a strategic partnership with US-based women’s and family healthcare provider, Maven Clinic.
The collaboration seeks to deliver fertility care to corporates in India by increasing access to treatment, and bringing to the fore the importance of incorporating fertility treatments in the country’s healthcare initiatives.
This is one of the first initiatives taken by an infertility treatment provider in the country to make fertility treatments accessible and affordable to the corporate workforce.
The partnership between Indira IVF and Maven Clinic entails treatments for employees of Maven Clinic’s partners at 10 metro locations in the country.
Maven’s virtual platform for family building care will be complemented by Indira IVF’s in-person support encompassing doctor consultation, treatment cycle, and egg and embryo storage.
Following Indira IVF’s latest investment introducing artificial intelligence (AI) in all its centres, the tie-up with Maven will benefit individuals working in these fast-paced environments.
The use of objective-based treatment and AI will decrease the total number of cycles required to achieve a pregnancy, which is especially important for individuals working in the corporate workforce since they have been observed to opt for treatment after the age of 35 years due to their increased focus on building a career in their late 20s and early 30s.
Speaking on the strategic partnership, Dr Nitiz Murdia, Co-Founder and Managing Director, Indira IVF, said: “Indira IVF is a technology-first organisation, employing the best-in-class technology to make parenthood a reality.
"In India, infertility bears societal consequences that can impact one’s emotional and mental wellbeing. We are thus, focussed on improving clinical outcomes by investing in technology such as AI to standardise processes across our 114 centres.
"Our collaboration with Maven Clinic will further the goal to provide equal access to our technology-oriented solutions, simultaneously stressing on the importance of timely treatment for infertility.”
Dr Kshitiz Murdia, Co-Founder and CEO, Indira IVF, said: “About 15 per cent of India’s total population suffers from infertility and we have observed that the conversations around infertility and IVF have gradually started to be discussed in the open.
"This is especially true in urban locations and among the corporate workforce where the erratic work life balance/lifestyle is adding up to reasons of infertility among young couples.
"As a cascade effect, organisations have realised the necessity of introducing healthcare benefits that focus on their employee’s fertility care.”
More News

Worldline launches Buland Bharat digital payments suite for stronger & inclusive India

27 Jan 2023 | 2:57 PM

Mumbai, Jan 27 (UNI) Worldline , a global leader in payments services, on Friday said it has launched Buland Bharat digital payments suite, which is designed specially keeping in mind the needs and wants of small and medium businesses (SMBs) in India.

see more..

Jio launches true 5G across all 6 states of North-East circle

27 Jan 2023 | 2:55 PM

Mumbai, Jan 27 (UNI) Reliance Jio on Friday said it has launched its True 5G services across all six states of North-East circle by connecting seven cities namely, Shillong, Imphal, Aizawl, Agartala, Itanagar, Kohima, and Dimapur with the transformational Jio True 5G network.

see more..

Edelweiss MF Launches Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index Fund

27 Jan 2023 | 2:55 PM

Mumbai, Jan 27 (UNI) Edelweiss Asset Management Limited on Friday said it launched Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index Fund, India’s first passive short-duration index fund.

see more..

27 Jan 2023 | 1:33 PM

Hyderabad, Jan 27 (UNI) Generic drug maker Dr. Reddy’s Laboratories Limited on Friday announced the launch of Dr. Reddy’s Difluprednate Ophthalmic Emulsion 0.05%, a therapeutic generic equivalent to Durezol® in the U.S. market.

see more..
Rupee falls 7 paise against USD

Rupee falls 7 paise against USD

27 Jan 2023 | 10:38 AM

Mumbai, Jan 27 (UNI) The Rupee on Friday slipped 7 paise at 81.65 in the opening trade against the US Dollar on rising demand for US Dollars by bankers and importers, dealers at Foreign Exchange said.

see more..